Insider Cluster (3 insiders) ·Filed May 22, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 3 insiders, $0.3M total
Actionable Insight • Neutral

These sales are routine tax-motivated transactions and carry no informational signal. UTHR has strong analyst sentiment and no material insider selling signal. Monitor the next earnings release and any change in the ongoing share buyback or pipeline developments for directional cues.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
UTHR ▼ -8.35% at T+60d
NEUTRAL call ✗ call lost -8.35% · α vs SPY -10.81% · entry $575.25 → $527.21
Entry anchored
May 22, 2026
via day open
T+1d
-1.31%
call -1.31% · α -1.32%
$567.74
settled 4mo ago
T+5d
-6.14%
call -6.14% · α -7.36%
$539.91
settled 4mo ago
T+20d
-5.38%
call -5.38% · α -3.11%
$544.33
settled 3mo ago
T+60d
-8.35%
call -8.35% · α -10.81%
$527.21
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Three UTHR insiders including the CEO, CFO, and EVP & General Counsel executed a series of option exercises and small open-market sales (total ~$331K) over May 18-21, 2026. The aggregate dollar value is negligible relative to the $24.0B market cap (~0.0014%), and the trades follow a pattern of near-simultaneous multi-leg option exercises with de minimis share sales — consistent with routine tax-withholding or cashless-exercise settlements, not informed selling.

Key Financial Metrics

Direction
selling
Total Value
$331.0K
Insiders
3

Key Facts

  • Three insiders — CEO Martine A. Rothblatt, CFO James Edgemond, and EVP Paul A. Mahon — sold a combined ~$331K of shares on the open market.
  • Sales are tiny relative to market cap (0.0014% of $24.0B), below the 0.1% threshold for materiality.
  • Every sale is paired with a simultaneous derivative exercise (option exercise at $0 to $146.03), indicating a tax-withholding or cashless exercise pattern.
  • All sales occurred within a 4-day window (May 18-21), consistent with a blackout-window opening post-earnings.
  • The common stock has been strong, with analyst consensus 77% bullish and a prior cluster of sells totaling the same $331K noted in the 30d snapshot — this appears to be a recurring quarterly pattern.

Financial Impact

Total insider sales of ~$331K, representing 0.0014% of the $24.0B market cap — economically trivial.

insider trading volume (negligible)

Risk Factors

  • No material risk indicated from this insider activity
  • The $24B market cap with 77% bullish consensus already prices in continued execution risk on the PAH (pulmonary arterial hypertension) portfolio and potential generic competition for Remodulin/Tyvaso.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1779484617555
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Closed — Opens in 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 22, 2026